1. Home
  2. TPST vs GORV Comparison

TPST vs GORV Comparison

Compare TPST & GORV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • GORV
  • Stock Information
  • Founded
  • TPST 2011
  • GORV 1976
  • Country
  • TPST United States
  • GORV United States
  • Employees
  • TPST N/A
  • GORV N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • GORV Retail-Auto Dealers and Gas Stations
  • Sector
  • TPST Health Care
  • GORV Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • GORV Nasdaq
  • Market Cap
  • TPST 33.0M
  • GORV 26.5M
  • IPO Year
  • TPST N/A
  • GORV 2015
  • Fundamental
  • Price
  • TPST $7.09
  • GORV $0.23
  • Analyst Decision
  • TPST Hold
  • GORV Hold
  • Analyst Count
  • TPST 3
  • GORV 2
  • Target Price
  • TPST $30.00
  • GORV $2.00
  • AVG Volume (30 Days)
  • TPST 245.0K
  • GORV 3.5M
  • Earning Date
  • TPST 08-07-2025
  • GORV 08-15-2025
  • Dividend Yield
  • TPST N/A
  • GORV N/A
  • EPS Growth
  • TPST N/A
  • GORV N/A
  • EPS
  • TPST N/A
  • GORV N/A
  • Revenue
  • TPST N/A
  • GORV $767,257,000.00
  • Revenue This Year
  • TPST N/A
  • GORV $15.65
  • Revenue Next Year
  • TPST N/A
  • GORV $20.54
  • P/E Ratio
  • TPST N/A
  • GORV N/A
  • Revenue Growth
  • TPST N/A
  • GORV N/A
  • 52 Week Low
  • TPST $5.35
  • GORV $0.13
  • 52 Week High
  • TPST $30.03
  • GORV $3.56
  • Technical
  • Relative Strength Index (RSI)
  • TPST 49.91
  • GORV 47.34
  • Support Level
  • TPST $6.87
  • GORV $0.21
  • Resistance Level
  • TPST $7.25
  • GORV $0.24
  • Average True Range (ATR)
  • TPST 0.67
  • GORV 0.02
  • MACD
  • TPST -0.02
  • GORV -0.00
  • Stochastic Oscillator
  • TPST 11.20
  • GORV 29.36

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About GORV Lazydays Holdings Inc.

Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.

Share on Social Networks: